The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Emergence of human immunodeficiency virus type 1 variants with resistance to multiple dideoxynucleosides in patients receiving therapy with dideoxynucleosides.
Open accessAbstract
A set of mutations [Ala-62-->Val(A62V), V75I, F77L, F116Y, and Q151M] in the polymerase domain of reverse transcriptase (RT) of human immunodeficiency virus type 1 (HIV-1) confers on the virus a reduced sensitivity to multiple antiretroviral dideoxynucleosides and has been seen in HIV-1 variants isolated from patients receiving combination chemotherapy with 3'-azido-3'-deoxythymidine (AZT) plus 2',3'-dideoxycytidine (ddC) or 2',3'-dideoxyinosine (ddI). The IC50 values of AZT, ddC, ddI, 2',3'-dideoxyguanosine, and 2',3'-didehydro-3'-deoxythymidine against an infectious clone constructed to include the five mutations were significantly higher than those of a wild-type infectious clone. The K1 value for AZT 5'-triphosphate determined for the virus-associated RT from a posttherapy strain was 35-fold higher than that of RT from a pretherapy strain. Detailed analysis of HIV-1 strains isolated at various times during therapy showed that the Q151M mutation developed first in vivo, at the time when the viremia level suddenly increased, followed by the F116Y and F77L mutations. All five mutations ultimately developed, and the viremia level rose even further. Analyses based on the three-dimensional structure of HIV-1 RT suggest that the positions where at least several of the five mutations occur are located in close proximity to the proposed dNTP-binding site of RT and the first nucleotide position of the single-stranded template.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current protocols in immunology
Nezlin, R. (1992) · Molecular Immunology · doi:10.1016/0161-5890(92)90114-d · Cited by 1,408
Identification of four conserved motifs among the RNA-dependent polymerase encoding elements.
Poch, O., Sauvaget, I., Delarue, M., & Tordo, N. (1989) · The EMBO Journal · doi:10.1002/j.1460-2075.1989.tb08565.x · Cited by 1,202
Multiple Mutations in HIV-1 Reverse Transcriptase Confer High-Level Resistance to Zidovudine (AZT)
Larder, B. A., & Kemp, S. D. (1989) · Science · doi:10.1126/science.2479983 · Cited by 1,163
Jacobo-Molina, A., Ding, J., Nanni, R. G., Clark, A. D., Lu, X., Tantillo, C., Williams, R. L., Kamer, G., Ferris, A. L., Clark, P., et al. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6320 · Cited by 1,115
Self-citationInhibition of HIV-1 Replication by a Nonnucleoside Reverse Transcriptase Inhibitor
Merluzzi, V. J., Hargrave, K. D., Labadia, M., Grozinger, K., Skoog, M., Wu, J. C., Shih, C.-K., Eckner, K., Hattox, S., Adams, J., et al. (1990) · Science · doi:10.1126/science.1701568 · Cited by 743
Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse Transcriptase
St. Clair, M. H., Martin, J. L., Tudor-Williams, G., Bach, M. C., Vavro, C. L., King, D. M., Kellam, P., Kemp, S. D., & Larder, B. A. (1991) · Science · doi:10.1126/science.1716788 · Cited by 679
Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus
McCune, J. M., Rabin, L. B., Feinberg, M. B., Lieberman, M., Kosek, J. C., Reyes, G. R., & Weissman, I. L. (1988) · Cell · doi:10.1016/0092-8674(88)90487-4 · Cited by 610
Characterization of Highly Immunogenic p66/p51 as the Reverse Transcriptase of HTLV-III/LAV
di Marzo Veronese, F., Copeland, T. D., DeVico, A. L., Rahman, R., Oroszlan, S., Gallo, R. C., & Sarngadharan, M. G. (1986) · Science · doi:10.1126/science.2418504 · Cited by 545
Tantillo, C., Ding, J., Jacobo-Molina, A., Nanni, R. G., Boyer, P. L., Hughes, S. H., Pauwels, R., Andries, K., Janssen, P. A. J., & Arnold, E. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1665 · Cited by 518
Self-citationYARCHOAN, R. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90283-8 · Cited by 512
Self-citationCharacterization of human immunodeficiency viruses resistant to oxathiolane-cytosine nucleosides
Schinazi, R. F., Lloyd, R. M., Nguyen, M. H., Cannon, D. L., McMillan, A., Ilksoy, N., Chu, C. K., Liotta, D. C., Bazmi, H. Z., & Mellors, J. W. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.875 · Cited by 364
Nunberg, J. H., Schleif, W. A., Boots, E. J., O'Brien, J. A., Quintero, J. C., Hoffman, J. M., Emini, E. A., & Goldman, M. E. (1991) · Journal of Virology · doi:10.1128/jvi.65.9.4887-4892.1991 · Cited by 363
HIV resistance to reverse transcriptase inhibitors
De Clercq, E. (1994) · Biochemical Pharmacology · doi:10.1016/0006-2952(94)90001-9 · Cited by 225
Gu, Z., Gao, Q., Fang, H., Salomon, H., Parniak, M. A., Goldberg, E., Cameron, J., & Wainberg, M. A. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.2.275 · Cited by 211
Shafer, R. W., Kozal, M. J., Winters, M. A., Iversen, A. K. N., Katzenstein, D. A., Ragni, M. V., Meyer, W. A., Gupta, P., Rasheed, S., Coombs, R., et al. (1994) · Journal of Infectious Diseases · doi:10.1093/infdis/169.4.722 · Cited by 205
Fitzgibbon, J. E., Howell, R. M., Haberzettl, C. A., Sperber, S. J., Gocke, D. J., & Dubin, D. T. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.153 · Cited by 194
Larder, B. A., Kemp, S. D., & Purifoy, D. J. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.4803 · Cited by 179
Boyer, P. L., Tantillo, C., Jacobo‐Molina, A., Nanni, R. G., Ding, J., Arnold, E., & Hughes, S. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4882 · Cited by 161
Self-citationShirasaka, T., Yarchoan, R., O'Brien, M. C., Husson, R. N., Anderson, B. D., Kojima, E., Shimada, T., Broder, S., & Mitsuya, H. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.562 · Cited by 139
Self-citationKozal, M. J., Shafer, R. W., Winters, M. A., Katzenstein, D. A., & Merigan, T. C. (1993) · The Journal of Infectious Diseases · doi:10.1093/infdis/167.3.526 · Cited by 132
Combination Therapy with Zidovudine and Didanosine Compared with Zidovudine Alone in HIV-1 Infection
Collier, A. C., Coombs, R. W., Fischl, M. A., Skolnik, P. R., Northfelt, D., Boutin, P., Hooper, C. J., Kaplan, L. D., Volberding, P. A., Davis, L. G., et al. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-119-8-199310150-00003 · Cited by 131
Kageyama, S., Mimoto, T., Murakawa, Y., Nomizu, M., Ford, H., Shirasaka, T., Gulnik, S., Erickson, J. W., Takada, K., & Hayashi, H. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.4.810 · Cited by 110
Self-citationYarchoan, R., Lietzau, J., Nguyen, B., Brawley, O. W., Pluda, J. M., Saville, M. W., Wyvill, K. M., Steinberg, S. M., Agbaria, R., Mitsuya, H., et al. (1994) · The Journal of Infectious Diseases · doi:10.1093/infdis/169.1.9 · Cited by 90
Self-citationMechanism of resistance of human immunodeficiency virus type 1 to 2',3'-dideoxyinosine.
Martin, J. L., Wilson, J. E., Haynes, R. L., & Furman, P. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6135 · Cited by 79
Plasma HIV-1 Viremia in HIV-1 Infected Individuals Assessed by Polymerase Chain Reaction
Sei, S., Yarchoan, R., Kageyama, S., HOEKZEMA, D. T., Pluda, J. M., Wyvill, K. M., Broder, S. E., & Mitsuya, H. (1992) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1992.8.1263 · Cited by 77
Self-citationEmini, E. A., Graham, D. J., Gotlib, L., Condra, J. H., & Byrnes, V. W. (1993) · Nature · doi:10.1038/364679b0 · Cited by 49
Cited by
Antiretroviral Therapy for HIV Infection: A Knowledge-Based Approach to Drug Selection and Use
Moyle, G. J., Gazzard, B. G., Cooper, D. A., & Gatell, J. (1998) · Drugs · doi:10.2165/00003495-199855030-00005 · Cited by 536
Hirsch, M. S., Brun‐Vezinet, F., Clotet, B., Conway, B., Kuritzkes, D. R., D’Aquila, R. T., Demeter, L. M., Hammer, S. M., Johnson, V. A., Loveday, C., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375597 · Cited by 514
Koh, Y., Nakata, H., Maeda, K., Ogata, H., Bilcer, G., Devasamudram, T., Kincaid, J. F., Boross, P., Wang, Y.-F., Tie, Y., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3123-3129.2003 · Cited by 367
Genotypic Testing for Human Immunodeficiency Virus Type 1 Drug Resistance
Shafer, R. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.247-277.2002 · Cited by 314
Sarafianos, S. G., Das, K., Clark, A. D., Ding, J., Boyer, P. L., Hughes, S. H., & Arnold, E. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.18.10027 · Cited by 309
Self-citation
Metadata
- Authors
- Shirasaka, T., Kavlick, M. F., Ueno, T., Gao, W. Y., Kojima, E., Alcaide, M. L., Chokekijchai, S., Roy, B. M., Arnold, E., & Yarchoan, R.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1995-03-14
- Volume
- 92
- Issue
- 6
- Pages
- 2398-2402
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2008428638
- Cited by
- 386
- References
- 26
- FWCI
- 19.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.